FITC Anti-Mouse CD90.2 Antibody[30H12]

The FITC Anti-Mouse CD90.2 Antibody [30H12] is a highly specific and reliable tool designed for the detection and analysis of CD90.2 expression in mouse samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a widely used fluorochrome known for its exceptional brightness and stability, ensuring accurate and consistent results.

CD90.2, also known as Thy1.2, is a glycosylphosphatidylinositol (GPI)-anchored membrane protein expressed on a variety of cell types, including hematopoietic stem cells, T cells, and fibroblasts. It plays a crucial role in cell-cell and cell-matrix interactions, as well as in signal transduction pathways. The FITC Anti-Mouse CD90.2 Antibody [30H12] specifically recognizes the extracellular domain of CD90.2, allowing for precise identification and characterization of CD90.2-positive cells.

This antibody has been extensively validated for flow cytometry applications, providing researchers with a powerful tool for immunophenotyping and cell sorting experiments. Its exceptional specificity and sensitivity enable the detection of even low levels of CD90.2 expression, ensuring accurate and reliable results. The FITC conjugation allows for easy visualization and quantification of CD90.2-positive cells, making it an ideal choice for multi-color flow cytometry experiments.

The FITC Anti-Mouse CD90.2 Antibody [30H12] is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody conjugation procedures. It is provided in a convenient 100 µg size, ensuring ample supply for multiple experiments. The antibody is formulated in a phosphate-buffered saline (PBS) solution containing 0.1% sodium azide, ensuring stability and long shelf life.

In summary, the FITC Anti-Mouse CD90.2 Antibody [30H12] is a highly specific and reliable tool for the detection and analysis of CD90.2 expression in mouse samples. Its exceptional specificity, sensitivity, and ease of use make it an invaluable resource for researchers studying CD90.2-positive cells in various biological contexts.